The NDP government has pledged to ban short-term sick note requirements in all workplaces before the end of the current ...

Patients in Canada may have to wait longer to access generic versions of Ozempic because of continuing delays in processing of new drug submissions at Health Canada, according to Swiss generic drug ...

The generic product is now available nationwide in strengths of 0.3mg, 0.45mg, 0.625mg, 0.9mg, and 1.25mg. The Food and Drug Administration (FDA) has approved the first generic version of Premarin ® ...

Anand Khanse is the Admin of TheWindowsClub.com, a 10-year Microsoft MVP (2006-16) & a Windows Insider MVP (2016-2022). Please read the entire post & the comments first, create a System Restore Point ...

The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate ...

A generic drug is a drug that can be manufactured and sold by any company, as long as they meet the stringent criteria for purity as required by Health Canada. It is usually sold under a generic name, ...

The FDA signed off on a second generic option for the abortion pill mifepristone on Tuesday, hours before most of the federal government shut down and despite Republican opposition to the drug. Evita ...

Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk’s injected Saxenda (liraglutide). The compound, ...

Generic versions of CSL’s iron replacement therapy Venofer have arrived in the U.S. after a yearslong wait. Monday, Viatris and Amphastar Pharmaceuticals both said they have received the FDA’s ...

Health Canada is taking longer to assess generic drug applications, lengthening the wait until the cheaper pharmaceuticals can come to market, new data show. The federal regulator’s delays mean that ...

There comes a time before every big purchase when you might ask yourself, “Do I really need this?” If you don’t pause for a moment — and if you tend to blow your budget as a result — then you need to ...

Kevin A. Schulman ([email protected]) is a professor of medicine at Stanford University, in Stanford, California. He is a board member and shareholder of Grid Therapeutics (an early stage ...